Skip to content

Clinical trials

Phase 1 Sarcoma trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Sarcoma Phase: Phase 1 Country / region: Italy Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20131
20141
20151
20161
20171
20181
20201
20212
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Recruiting2
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company2
Italian Sarcoma Group2
Deciphera Pharmaceuticals, LLC1
Foghorn Therapeutics Inc.1
GlaxoSmithKline1
Inhibrx Biosciences, Inc1
Philogen S.p.A.1
Prof. Franca Fagioli1
Valo Therapeutics Oy1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Sarcoma11
Breast Neoplasms2
Carcinoma, Non-Small-Cell Lung2
Melanoma2
Osteosarcoma2
Sarcoma, Synovial2
Bone Neoplasms1
Colorectal Neoplasms1
Gastrointestinal Stromal Tumors1
Glioma1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.